Interventions for rosacea

A study on the epidemiology of rosacea in the U.K.

“…Overall, the IR of GP‐diagnosed rosacea in the U.K. was 1·65 per 1000 py (95% CI 1·63–1·66), with higher IRs in females. Rosacea also tended to be diagnosed earlier in women than in men, a finding consistent with other studies, and usually developed after the age of 30 years 1,2,9–11,18,25,26 . We further observed a slight increase in the crude and age‐standardised IRs over the course of the study period until 2002, as was reported by the authors of a U.S.‐based publication from 2002 12 .…”

A study on the epidemiology of rosacea in the U.K.

“…Overall, the IR of GP‐diagnosed rosacea in the U.K. was 1·65 per 1000 py (95% CI 1·63–1·66), with higher IRs in females. Rosacea also tended to be diagnosed earlier in women than in men, a finding consistent with other studies, and usually developed after the age of 30 years 1,2,9–11,18,25,26 . We further observed a slight increase in the crude and age‐standardised IRs over the course of the study period until 2002, as was reported by the authors of a U.S.‐based publication from 2002 12 .…”

Long‐term inflammatory rosacea management with subantibiotic dose oral doxycycline 40 mg modified‐release capsules once daily

“…Likewise, even among subjects who did not relapse and were completely clear at the beginning of Part 2, there was a trend towards increased inflammatory lesion numbers in the placebo group. Previous studies have established that SDD 40 significantly improves efficacy compared to topical therapy alone, supporting the use of multiple strategies to simultaneously target the signs and symptoms of rosacea 3–4,7–8 . Indeed, rosacea not only carries a high burden for visible manifestations, but also invisible symptoms such as stinging and burning that in our study were decreased with SDD 40 monotherapy after successful treatment with combination therapy.…”

Rosacea and perioral dermatitis: a single‐center retrospective analysis of the clinical presentation of 1032 patients

“…In our study, we found that a great majority of patients (94.3 %) were prescribed topical medication as monotherapy or in combination with systemic agents. This could be explained by the fact that topical treatment, alone or as part of a combination regime, has proven to be adequate in most patients with ETR or PPR [36], which, according to our results, were also the most frequent phenotypes. Moreover, due to the high recurrence rate as a chronic inflammatory skin disease, topical maintenance therapy is further recommended for long-term improvement [35].…”

A study on the epidemiology of rosacea in the U.K.

“…Overall, the IR of GP‐diagnosed rosacea in the U.K. was 1·65 per 1000 py (95% CI 1·63–1·66), with higher IRs in females. Rosacea also tended to be diagnosed earlier in women than in men, a finding consistent with other studies, and usually developed after the age of 30 years 1,2,9–11,18,25,26 . We further observed a slight increase in the crude and age‐standardised IRs over the course of the study period until 2002, as was reported by the authors of a U.S.‐based publication from 2002 12 .…”

Long‐term inflammatory rosacea management with subantibiotic dose oral doxycycline 40 mg modified‐release capsules once daily

“…Likewise, even among subjects who did not relapse and were completely clear at the beginning of Part 2, there was a trend towards increased inflammatory lesion numbers in the placebo group. Previous studies have established that SDD 40 significantly improves efficacy compared to topical therapy alone, supporting the use of multiple strategies to simultaneously target the signs and symptoms of rosacea 3–4,7–8 . Indeed, rosacea not only carries a high burden for visible manifestations, but also invisible symptoms such as stinging and burning that in our study were decreased with SDD 40 monotherapy after successful treatment with combination therapy.…”

Rosacea and perioral dermatitis: a single‐center retrospective analysis of the clinical presentation of 1032 patients

“…In our study, we found that a great majority of patients (94.3 %) were prescribed topical medication as monotherapy or in combination with systemic agents. This could be explained by the fact that topical treatment, alone or as part of a combination regime, has proven to be adequate in most patients with ETR or PPR [36], which, according to our results, were also the most frequent phenotypes. Moreover, due to the high recurrence rate as a chronic inflammatory skin disease, topical maintenance therapy is further recommended for long-term improvement [35].…”

A study on the epidemiology of rosacea in the U.K.

“…Overall, the IR of GP‐diagnosed rosacea in the U.K. was 1·65 per 1000 py (95% CI 1·63–1·66), with higher IRs in females. Rosacea also tended to be diagnosed earlier in women than in men, a finding consistent with other studies, and usually developed after the age of 30 years 1,2,9–11,18,25,26 . We further observed a slight increase in the crude and age‐standardised IRs over the course of the study period until 2002, as was reported by the authors of a U.S.‐based publication from 2002 12 .…”

Long‐term inflammatory rosacea management with subantibiotic dose oral doxycycline 40 mg modified‐release capsules once daily

“…Likewise, even among subjects who did not relapse and were completely clear at the beginning of Part 2, there was a trend towards increased inflammatory lesion numbers in the placebo group. Previous studies have established that SDD 40 significantly improves efficacy compared to topical therapy alone, supporting the use of multiple strategies to simultaneously target the signs and symptoms of rosacea 3–4,7–8 . Indeed, rosacea not only carries a high burden for visible manifestations, but also invisible symptoms such as stinging and burning that in our study were decreased with SDD 40 monotherapy after successful treatment with combination therapy.…”

Rosacea and perioral dermatitis: a single‐center retrospective analysis of the clinical presentation of 1032 patients

“…In our study, we found that a great majority of patients (94.3 %) were prescribed topical medication as monotherapy or in combination with systemic agents. This could be explained by the fact that topical treatment, alone or as part of a combination regime, has proven to be adequate in most patients with ETR or PPR [36], which, according to our results, were also the most frequent phenotypes. Moreover, due to the high recurrence rate as a chronic inflammatory skin disease, topical maintenance therapy is further recommended for long-term improvement [35].…”